WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹500 Cr | ₹511 Cr | ₹393 Cr | ₹367 Cr | ₹391 Cr |
What is the latest Revenue of WANBURY ?
Year | Revenue |
---|---|
Mar2024 | ₹500 Cr |
Mar2023 | ₹511 Cr |
Mar2022 | ₹393 Cr |
Mar2021 | ₹367 Cr |
Mar2020 | ₹391 Cr |
How is Revenue of WANBURY Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹500 Cr | -2.26 | |
Mar2023 | ₹511 Cr | 30.23 | |
Mar2022 | ₹393 Cr | 6.82 | |
Mar2021 | ₹367 Cr | -6.11 | |
Mar2020 | ₹391 Cr | - |
Compare Revenue of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹945.9 Cr | 14.1% | 8% | 38.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,419.0 Cr | -0.2% | -2.3% | -7.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | -1.7% | -8.8% | 27.2% | Stock Analytics | |
CIPLA | ₹128,659.0 Cr | 1.9% | 8.7% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,448.0 Cr | 0.7% | 4.1% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,539.0 Cr | 1.4% | 2.9% | -10.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 14.1% |
8% |
38.8% |
SENSEX | 1.8% |
-0.2% |
2% |
You may also like the below Video Courses